Benefits and Risks of Inhaled Corticosteroid Treatment in Patients with Chronic Obstructive Pulmonary Disease Classified by Blood Eosinophil Counts
Zenya Saito,Masahiro Yoshida,Ayako Kojima,Kentaro Tamura,Tsukasa Hasegawa,Kazuyoshi Kuwano
DOI: https://doi.org/10.1007/s00408-020-00397-4
2020-10-17
Lung
Abstract:Chronic obstructive pulmonary disease (COPD) typically includes neutrophilic airway inflammation and eosinophilic inflammation in some cases. Inhaled corticosteroid (ICS) suppresses eosinophilic inflammation of the airway and reduces acute exacerbation (AE). The present study investigated the relationship between ICS and AE in patients with COPD classified by blood eosinophil counts.
respiratory system
What problem does this paper attempt to address?